Rhythm Pharmaceuticals (RYTM) Payables (2016 - 2025)
Historic Payables for Rhythm Pharmaceuticals (RYTM) over the last 10 years, with Q3 2025 value amounting to $13.6 million.
- Rhythm Pharmaceuticals' Payables rose 17892.37% to $13.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.6 million, marking a year-over-year increase of 17892.37%. This contributed to the annual value of $12.3 million for FY2024, which is 15236.44% up from last year.
- According to the latest figures from Q3 2025, Rhythm Pharmaceuticals' Payables is $13.6 million, which was up 17892.37% from $16.0 million recorded in Q2 2025.
- Rhythm Pharmaceuticals' Payables' 5-year high stood at $16.0 million during Q2 2025, with a 5-year trough of $3.8 million in Q3 2023.
- Moreover, its 5-year median value for Payables was $6.0 million (2022), whereas its average is $8.1 million.
- As far as peak fluctuations go, Rhythm Pharmaceuticals' Payables plummeted by 4580.7% in 2024, and later skyrocketed by 25179.4% in 2025.
- Over the past 5 years, Rhythm Pharmaceuticals' Payables (Quarter) stood at $5.7 million in 2021, then fell by 16.38% to $4.8 million in 2022, then rose by 1.83% to $4.9 million in 2023, then soared by 152.36% to $12.3 million in 2024, then grew by 10.57% to $13.6 million in 2025.
- Its Payables stands at $13.6 million for Q3 2025, versus $16.0 million for Q2 2025 and $11.9 million for Q1 2025.